Visentin A, Mauro FR, Cibien F, Vitale C, et al. Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study. Am J Hematol 2021 Dec 14. doi: 10.1002/ajh.26437.
PMID: 34904743